Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 19,3x - 21,3x | 20,3x |
| Selected Fwd EBITDA Multiple | 10,4x - 11,5x | 10,9x |
| Fair Value | 3.313₩ - 3.952₩ | 3.633₩ |
| Upside | -10,6% - 6,7% | -2,0% |
| Benchmarks | Ticker | Full Ticker |
| LK CHEM Co., Ltd. | A489500 | KOSDAQ:A489500 |
| Youngbo Chemical Co., Ltd. | A014440 | KOSE:A014440 |
| Cell Bio Human Tech Co.,Ltd | A318160 | KOSDAQ:A318160 |
| Assems Inc. | A136410 | KOSDAQ:A136410 |
| KNW Co., Ltd. | A105330 | KOSDAQ:A105330 |
| InkTec Co., Ltd. | A049550 | KOSDAQ:A049550 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| A489500 | A014440 | A318160 | A136410 | A105330 | A049550 | ||
| KOSDAQ:A489500 | KOSE:A014440 | KOSDAQ:A318160 | KOSDAQ:A136410 | KOSDAQ:A105330 | KOSDAQ:A049550 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | NM- | 10.4% | 0.8% | 13.8% | NM- | 22.0% | |
| 3Y CAGR | NM- | 28.8% | -6.0% | 13.9% | -35.9% | -15.1% | |
| Latest Twelve Months | 79.3% | 84.3% | 20.0% | 40.8% | -70.4% | -14.2% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 41.9% | 16.7% | 18.8% | 19.0% | 7.9% | 11.7% | |
| Prior Fiscal Year | 41.3% | 16.9% | 18.1% | 17.2% | 11.3% | 10.7% | |
| Latest Fiscal Year | 45.1% | 23.9% | 20.9% | 20.2% | 4.1% | 7.8% | |
| Latest Twelve Months | 45.1% | 23.9% | 20.9% | 20.2% | 4.1% | 7.8% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.67x | 0.44x | 1.21x | 1.96x | 0.55x | 1.72x | |
| EV / LTM EBITDA | 12.6x | 1.9x | 5.8x | 9.7x | 13.5x | 22.1x | |
| EV / LTM EBIT | 14.0x | 2.7x | 8.5x | 12.2x | -18.8x | 47.2x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 1.9x | 9.7x | 13.5x | ||||
| Historical EV / LTM EBITDA | 11.3x | 21.3x | 67.9x | ||||
| Selected EV / LTM EBITDA | 19.3x | 20.3x | 21.3x | ||||
| (x) LTM EBITDA | 5,754 | 5,754 | 5,754 | ||||
| (=) Implied Enterprise Value | 111,056 | 116,901 | 122,746 | ||||
| (-) Non-shareholder Claims * | (53,980) | (53,980) | (53,980) | ||||
| (=) Equity Value | 57,076 | 62,921 | 68,766 | ||||
| (/) Shares Outstanding | 19.6 | 19.6 | 19.6 | ||||
| Implied Value Range | 2,911.11 | 3,209.23 | 3,507.35 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 2,911.11 | 3,209.23 | 3,507.35 | 3,705.00 | |||
| Upside / (Downside) | -21.4% | -13.4% | -5.3% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A489500 | A014440 | A318160 | A136410 | A105330 | A049550 | |
| Enterprise Value | 142,024 | 52,124 | 34,374 | 111,165 | 42,971 | 126,621 | |
| (+) Cash & Short Term Investments | 14,398 | 51,044 | 14,306 | 12,744 | 74,705 | 2,909 | |
| (+) Investments & Other | 54 | 191 | 1,034 | 932 | 886 | 328 | |
| (-) Debt | (4,201) | (205) | (4,068) | (29,646) | (53,414) | (57,217) | |
| (-) Other Liabilities | (32) | 0 | 0 | (2,305) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | (447) | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 152,243 | 103,155 | 45,200 | 92,890 | 65,148 | 72,641 | |
| (/) Shares Outstanding | 6.3 | 19.5 | 8.5 | 10.6 | 15.9 | 19.6 | |
| Implied Stock Price | 24,250.00 | 5,290.00 | 5,330.00 | 8,780.00 | 4,105.00 | 3,705.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 24,250.00 | 5,290.00 | 5,330.00 | 8,780.00 | 4,105.00 | 3,705.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |